Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Clinical trial NCT06624839 · RECRUITING

Trial details

NCT number: NCT06624839
Sponsor: University of Maryland, Baltimore
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Human Papilloma Virus Anal Dysplasia HIV

Start date: 2025-03-15
Primary completion: 2027-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.